Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients.

Source:http://linkedlifedata.com/resource/pubmed/id/19383734

Download in:

View as

General Info

PMID
19383734